Neurofeedback for Non-Motor Symptoms in Early Parkinson’s Disease: Cognitive and Emotional Outcomes from an SMR Training Protocol

<p>This chapter reports cognitive and emotional outcomes from a feasible trial of sensorimotor rhythm (SMR-12&ndash;15&thinsp;Hz) neurofeedback (NFB) in patients with early Parkinson&rsquo;s disease (PD). Eight participants (mean age 65.25&thinsp;&plusmn;&thinsp;5.75) were distributed into three gro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Kouzak, Valeska
Formato: Capítulo de libro
Lenguaje:inglés
Publicado: IntechOpen 2026
Materias:
Acceso en línea:https://www.intechopen.com/chapters/1245049
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:<p>This chapter reports cognitive and emotional outcomes from a feasible trial of sensorimotor rhythm (SMR-12&ndash;15&thinsp;Hz) neurofeedback (NFB) in patients with early Parkinson&rsquo;s disease (PD). Eight participants (mean age 65.25&thinsp;&plusmn;&thinsp;5.75) were distributed into three groups: NFB, sham-NFB (S-NFB), or waitlist (Non-NFB). They completed pre- and post-training assessments, including the Parkinson Disease Cognitive Rating Scale (PD-CRS), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI). Ten NFB sessions targeted SMR at Cz using a respiration-guided protocol. Cognitive outcomes demonstrated that the NFB group showed significant improvement in cognition (PD-CRS total; <i>p</i>&thinsp;&lt;0.05) and in the subcomponents, that is, frontal&ndash;subcortical (<i>p</i>&thinsp;=&thinsp;0.009) and cortical&ndash;posterior (<i>p</i>&thinsp;=&thinsp;0.035). The S-NFB group showed a significant change in PD-CRS total but not in component subscores. Emotional outcomes demonstrated that the NFB group had significant reductions in anxiety (BAI; <i>p</i>&thinsp;&lt;0.05) and depression (BDI; <i>p</i>&thinsp;&lt;0.05), while controls did not. Consequently, these results indicate that SMR neurofeedback can yield clinically relevant cognitive and affective benefits in early PD.</p>
ISBN:978-1-80631-934-3
DOI:10.5772/intechopen.1015580